Phaco linked to posterior capsule rupture

Article

Phacoemulsification is linked to a higher rate of posterior capsule rupture in vitrectomized eyes, compared to combined vitrectomy and cataract surgery.

Phacoemulsification is linked to a higher rate of posterior capsule rupture in vitrectomized eyes, compared to combined vitrectomy and cataract surgery, claimed a paper in Retina.

Dr Jong Yeon Lee et al., Department of Ophthalmology, Gachon University Gil Hospital, Incheon, Korea, retrospectively reviewed the medical records of 54 patients who underwent cataract surgery in eyes that had previously been vitrectomized and 311 patients who experienced combined vitrectomy and cataract surgery. The main primary outcome measure was intraoperative complications during phacoemulsification and the secondary measures were preoperative and intraoperative cataract gradings.

It was discovered that the most common complication during phacoemulsification was posterior capsule rupture. The rate was higher in the sequential group than in the combined group, as was preoperative lens density.

Hard nucleus cataracts in vitrectomized eyes could have caused the higher rate of posterior capsule rupture in the sequential group.

Please click here for the abstract.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.